In order to treat obesity, patients with a BMI of 30 kg/m2 or more are prescribed ORLIFIT (orlistat) in conjunction with a reduced-calorie diet. Patients who are overweight and have a BMI of 27 kg/m2 or more, along with risk factors like diabetes, dyslipidemia, and hypertension, may also utilize it.